These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

770 related articles for article (PubMed ID: 1283267)

  • 1. [Hodgkin's disease--an entity?].
    Hansmann ML
    Verh Dtsch Ges Pathol; 1992; 76():24-36. PubMed ID: 1283267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fascin, a sensitive new marker for Reed-Sternberg cells of hodgkin's disease. Evidence for a dendritic or B cell derivation?
    Pinkus GS; Pinkus JL; Langhoff E; Matsumura F; Yamashiro S; Mosialos G; Said JW
    Am J Pathol; 1997 Feb; 150(2):543-62. PubMed ID: 9033270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hodgkin's disease, lymphocyte predominance type, nodular--further evidence for a B cell derivation. L & H variants of Reed-Sternberg cells express L26, a pan B cell marker.
    Pinkus GS; Said JW
    Am J Pathol; 1988 Nov; 133(2):211-7. PubMed ID: 3263805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histiocyte-rich B-cell lymphoma. A distinct clinicopathologic entity possibly related to lymphocyte predominant Hodgkin's disease, paragranuloma subtype.
    Delabie J; Vandenberghe E; Kennes C; Verhoef G; Foschini MP; Stul M; Cassiman JJ; De Wolf-Peeters C
    Am J Surg Pathol; 1992 Jan; 16(1):37-48. PubMed ID: 1728195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD30 distribution. Immunohistochemical study on formaldehyde-fixed, paraffin-embedded Hodgkin's and non-Hodgkin's lymphomas.
    Miettinen M
    Arch Pathol Lab Med; 1992 Nov; 116(11):1197-201. PubMed ID: 1332642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Light-chain mRNA in lymphocyte-predominant and mixed-cellularity Hodgkin's disease.
    von Wasielewski R; Wilkens L; Nolte M; Werner M; Georgii A
    Mod Pathol; 1996 Mar; 9(3):334-8. PubMed ID: 8685237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-bet, a T cell-associated transcription factor, is expressed in Hodgkin's lymphoma.
    Dorfman DM; Hwang ES; Shahsafaei A; Glimcher LH
    Hum Pathol; 2005 Jan; 36(1):10-5. PubMed ID: 15712176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular analysis of the t(14;18) chromosomal translocation in malignant lymphomas.
    Weiss LM; Warnke RA; Sklar J; Cleary ML
    N Engl J Med; 1987 Nov; 317(19):1185-9. PubMed ID: 3657890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histopathology of Hodgkin's lymphoma.
    Eberle FC; Mani H; Jaffe ES
    Cancer J; 2009; 15(2):129-37. PubMed ID: 19390308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lymphoid depletion type 4 Hodgkin disease. Anatomoclinical review of 35 cases].
    Eghbali H; Pétorin C; de Mascarel I; Trojani M; Hoerni-Simon G; Soubeyran P; Hoerni B
    Bull Cancer; 1994 Oct; 81(10):866-70. PubMed ID: 7734769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The relations between Hodgkin's and non-Hodgkin's lymphoma].
    Lennert K
    Arzneimittelforschung; 1987 Feb; 37(2A):255-9. PubMed ID: 3566873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendritic reticulum cell immunoreactivity for low-affinity nerve growth factor receptor in malignant lymphomas.
    Dorfman DM; Shahsafaei A
    Mod Pathol; 1996 Oct; 9(10):959-65. PubMed ID: 8902831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interrelationship of Hodgkin's disease and non-Hodgkin's lymphomas--lessons learned from composite and sequential malignancies.
    Jaffe ES; Zarate-Osorno A; Medeiros LJ
    Semin Diagn Pathol; 1992 Nov; 9(4):297-303. PubMed ID: 1480852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuron-specific enolase (gamma enolase, gamma-gamma dimer) expression in Hodgkin's disease and large cell lymphomas.
    Massarelli G; Onida GA; Piras MA; Marras V; Mura A; Tanda F
    Anticancer Res; 1999; 19(5B):3933-8. PubMed ID: 10628334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demonstration of light chain mRNA in Hodgkin's disease.
    Hell K; Pringle JH; Hansmann ML; Lorenzen J; Colloby P; Lauder I; Fischer R
    J Pathol; 1993 Oct; 171(2):137-43. PubMed ID: 8283350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Histopathology of malignant lymphomas].
    Yamabe H
    Rinsho Byori; 1990 Apr; 38(4):386-9. PubMed ID: 2195192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of cell proliferation index in assessing histological prognostic categories in Hodgkin's disease. An immunohistochemical study with Ki67 and MIB-1 monoclonal antibodies.
    Abele MC; Valente G; Kerim S; Navone R; Onesti P; Chiusa L; Resegotti L; Palestro G
    Haematologica; 1997; 82(3):281-5. PubMed ID: 9234572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. REAL classification of malignant lymphomas in the Republic of Korea: incidence of recently recognized entities and changes in clinicopathologic features. Hematolymphoreticular Study Group of the Korean Society of Pathologists. Revised European-American lymphoma.
    Ko YH; Kim CW; Park CS; Jang HK; Lee SS; Kim SH; Ree HJ; Lee JD; Kim SW; Huh JR
    Cancer; 1998 Aug; 83(4):806-12. PubMed ID: 9708949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How to differentiate between T-cell-rich B-cell lymphoma and lymphocyte-predominant Hodgkin's disease. Evidence for the value of MB1 and 4KB5 immunostaining.
    Schmidt U; Herbst J; Metz KA; Leder LD
    J Pathol; 1996 Jun; 179(2):138-44. PubMed ID: 8758204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphomas in Iran.
    Hashemi-Bahremani M; Parwaresch MR; Tabrizchi H; Gupta RK; Raffii MR
    Arch Iran Med; 2007 Jul; 10(3):343-8. PubMed ID: 17604472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.